{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:00:34Z","timestamp":1794085234550,"version":"4.8.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-022-03509-1","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T03:37:11Z","timestamp":1649734631000},"page":"3993-4004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gastric neuroendocrine neoplasms: a primer for radiologists"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-1487","authenticated-orcid":false,"given":"Molly E.","family":"Roseland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac R.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6094-1676","authenticated-orcid":false,"given":"Kimberly L.","family":"Shampain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7339-8107","authenticated-orcid":false,"given":"Erica B.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4823-8929","authenticated-orcid":false,"given":"Ashish P.","family":"Wasnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6703-8818","authenticated-orcid":false,"given":"John D.","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"issue":"2","key":"3509_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2019","unstructured":"Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, K. M., Carneiro, F., Cree, I. A., & Board, W. H. O. C. o. T. E. (2020, Jan). The 2019 WHO classification of tumours of the digestive system. Histopathology, 76(2), 182-188. https:\/\/doi.org\/10.1111\/his.13975","journal-title":"Histopathology"},{"issue":"10","key":"3509_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., Shih, T., & Yao, J. C. (2017, Oct 1). Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol, 3(10), 1335-1342. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"issue":"4","key":"3509_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","volume":"23","author":"S Das","year":"2021","unstructured":"Das, S., & Dasari, A. (2021, Mar 14). Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? Curr Oncol Rep, 23(4), 43. https:\/\/doi.org\/10.1007\/s11912-021-01029-7","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"3509_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin, I. M., Lye, K. D., & Kidd, M. (2003, Feb 15). A 5-decade analysis of 13,715 carcinoid tumors. Cancer, 97(4), 934-959. https:\/\/doi.org\/10.1002\/cncr.11105","journal-title":"Cancer"},{"issue":"11","key":"3509_CR5","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.cgh.2018.12.017","volume":"17","author":"MR Lee","year":"2019","unstructured":"Lee, M. R., Harris, C., Baeg, K. J., Aronson, A., Wisnivesky, J. P., & Kim, M. K. (2019, Oct). Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States. Clin Gastroenterol Hepatol, 17(11), 2212-2217 e2211. https:\/\/doi.org\/10.1016\/j.cgh.2018.12.017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"3509_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ecl.2018.04.013","volume":"47","author":"S Grozinsky-Glasberg","year":"2018","unstructured":"Grozinsky-Glasberg, S., Alexandraki, K. I., Angelousi, A., Chatzellis, E., Sougioultzis, S., & Kaltsas, G. (2018, Sep). Gastric Carcinoids. Endocrinol Metab Clin North Am, 47(3), 645-660. https:\/\/doi.org\/10.1016\/j.ecl.2018.04.013","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"3509_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MPA.0000000000001707","volume":"50","author":"E Kessel","year":"2021","unstructured":"Kessel, E., Naparst, M., Alpert, N., Diaz, K., Ahn, E., Wolin, E., Taioli, E., & Kim, M. K. (2021, Jan 1). Racial Differences in Gastroenteropancreatic Neuroendocrine Tumor Treatment and Survival in the United States. Pancreas, 50(1), 29-36. https:\/\/doi.org\/10.1097\/MPA.0000000000001707","journal-title":"Pancreas"},{"issue":"10","key":"3509_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ejso.2018.01.082","volume":"44","author":"LL Cao","year":"2018","unstructured":"Cao, L. L., Lu, J., Lin, J. X., Zheng, C. H., Li, P., Xie, J. W., Wang, J. B., Chen, Q. Y., Lin, M., Tu, R. H., & Huang, C. M. (2018, Oct). Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database. Eur J Surg Oncol, 44(10), 1628-1633. https:\/\/doi.org\/10.1016\/j.ejso.2018.01.082","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"3509_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.path.2019.08.007","volume":"12","author":"N Patel","year":"2019","unstructured":"Patel, N., Barbieri, A., & Gibson, J. (2019, Dec). Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas. Surg Pathol Clin, 12(4), 1021-1044. https:\/\/doi.org\/10.1016\/j.path.2019.08.007","journal-title":"Surg Pathol Clin"},{"issue":"3","key":"3509_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.path.2020.04.002","volume":"13","author":"RS Gonzalez","year":"2020","unstructured":"Gonzalez, R. S. (2020). Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms [Review]. Surgical Pathology Clinics, 13(3), 377-397. https:\/\/doi.org\/10.1016\/j.path.2020.04.002","journal-title":"Surgical Pathology Clinics"},{"key":"3509_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12022-013-9292-5","volume":"25","author":"GPG Rindi","year":"2014","unstructured":"Rindi, G. P., G.; Inzani F. (2014). 25 Years of Neuroendocrine Neoplasms of the Gastrointestinal Tract. Endocr Pathol, 25, 59-64. https:\/\/doi.org\/10.1007\/s12022-013-9292-5","journal-title":"Endocr Pathol"},{"key":"3509_CR12","unstructured":"National Comprehensive Cancer Network (2021). Neuroendocrine and Adrenal Cancers (Verson 4.2021). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf"},{"key":"3509_CR13","doi-asserted-by":"publisher","first-page":"188637","DOI":"10.1016\/j.bbcan.2021.188637","volume":"1876","author":"M Shi","year":"2021","unstructured":"Shi, M. F. Z. X. J. Y. J. L. Y. G. C. S. P. W. X. Z. H. (2021). Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs. BBA - Reviews on Cancer, 1876(188637). https:\/\/doi.org\/10.1016\/j.bbcan.2021.188637","journal-title":"BBA Reviews on Cancer"},{"issue":"6","key":"3509_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","volume":"39","author":"MH Kulke","year":"2010","unstructured":"Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., Jensen, R. T., & North American Neuroendocrine Tumor, S. (2010, Aug). NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas, 39(6), 735-752. https:\/\/doi.org\/10.1097\/MPA.0b013e3181ebb168","journal-title":"Pancreas"},{"issue":"2","key":"3509_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000443168","volume":"103","author":"G Delle Fave","year":"2016","unstructured":"Delle Fave, G., O'Toole, D., Sundin, A., Taal, B., Ferolla, P., Ramage, J. K., Ferone, D., Ito, T., Weber, W., Zheng-Pei, Z., De Herder, W. W., Pascher, A., Ruszniewski, P., & Vienna Consensus Conference, p. (2016). ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology, 103(2), 119-124. https:\/\/doi.org\/10.1159\/000443168","journal-title":"Neuroendocrinology"},{"issue":"3","key":"3509_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin, A., Arnold, R., Baudin, E., Cwikla, J. B., Eriksson, B., Fanti, S., Fazio, N., Giammarile, F., Hicks, R. J., Kjaer, A., Krenning, E., Kwekkeboom, D., Lombard-Bohas, C., O'Connor, J. M., O'Toole, D., Rockall, A., Wiedenmann, B., Valle, J. W., Vullierme, M. P., & Antibes Consensus Conference, p. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging. Neuroendocrinology, 105(3), 212-244. https:\/\/doi.org\/10.1159\/000471879","journal-title":"Neuroendocrinology"},{"issue":"7","key":"3509_CR17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel, M., Oberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A., Berruti, A., & clinicalguidelines@esmo.org, E. G. C. E. a. (2020, Jul). Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 31(7), 844-860. https:\/\/doi.org\/10.1016\/j.annonc.2020.03.304","journal-title":"Ann Oncol"},{"issue":"1","key":"3509_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1148\/radiol.12112512","volume":"266","author":"DV Sahani","year":"2013","unstructured":"Sahani, D. V., Bonaffini, P. A., Fernandez-Del Castillo, C., & Blake, M. A. (2013, Jan). Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology, 266(1), 38-61. https:\/\/doi.org\/10.1148\/radiol.12112512","journal-title":"Radiology"},{"issue":"1","key":"3509_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.soc.2015.08.008","volume":"25","author":"JE Maxwell","year":"2016","unstructured":"Maxwell, J. E., O'Dorisio, T. M., & Howe, J. R. (2016, Jan). Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am, 25(1), 171-194. https:\/\/doi.org\/10.1016\/j.soc.2015.08.008","journal-title":"Surg Oncol Clin N Am"},{"key":"3509_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009944.pub2","author":"S Mocellin","year":"2015","unstructured":"Mocellin, S., & Pasquali, S. (2015, Feb 6). Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev(2), CD009944. https:\/\/doi.org\/10.1002\/14651858.CD009944.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3509_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.suc.2016.11.008","volume":"97","author":"B Corey","year":"2017","unstructured":"Corey, B., & Chen, H. (2017, Apr). Neuroendocrine Tumors of the Stomach. Surg Clin North Am, 97(2), 333-343. https:\/\/doi.org\/10.1016\/j.suc.2016.11.008","journal-title":"Surg Clin North Am"},{"issue":"2","key":"3509_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.soc.2019.10.002","volume":"29","author":"JS Dillon","year":"2020","unstructured":"Dillon, J. S. (2020, Apr). Workup of Gastroenteropancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am, 29(2), 165-183. https:\/\/doi.org\/10.1016\/j.soc.2019.10.002","journal-title":"Surg Oncol Clin N Am"},{"key":"3509_CR23","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.27159","author":"SJ Galgano","year":"2022","unstructured":"Galgano, S. J., Iravani, A., Bodei, L., El-Haddad, G., Hofman, M. S., & Kong, G. (2022, Jan 5). Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.21.27159","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"3509_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.beem.2016.01.003","volume":"30","author":"T Baumann","year":"2016","unstructured":"Baumann, T., Rottenburger, C., Nicolas, G., & Wild, D. (2016, Jan). Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging. Best Pract Res Clin Endocrinol Metab, 30(1), 45-57. https:\/\/doi.org\/10.1016\/j.beem.2016.01.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"3509_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1148\/radiol.13121628","volume":"268","author":"G d'Assignies","year":"2013","unstructured":"d'Assignies, G., Fina, P., Bruno, O., Vullierme, M. P., Tubach, F., Paradis, V., Sauvanet, A., Ruszniewski, P., & Vilgrain, V. (2013, Aug). High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology, 268(2), 390-399. https:\/\/doi.org\/10.1148\/radiol.13121628","journal-title":"Radiology"},{"issue":"3","key":"3509_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPA.0000000000000461","volume":"45","author":"A Farchione","year":"2016","unstructured":"Farchione, A., Rufini, V., Brizi, M. G., Iacovazzo, D., Larghi, A., Massara, R. M., Petrone, G., Poscia, A., Treglia, G., De Marinis, L., Giordano, A., Rindi, G., & Bonomo, L. (2016, Mar). Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography\/Computed Tomography. Pancreas, 45(3), 345-354. https:\/\/doi.org\/10.1097\/MPA.0000000000000461","journal-title":"Pancreas"},{"issue":"12","key":"3509_CR27","doi-asserted-by":"publisher","first-page":"6593","DOI":"10.1007\/s00330-020-06930-6","volume":"30","author":"R Hayoz","year":"2020","unstructured":"Hayoz, R., Vietti-Violi, N., Duran, R., Knebel, J. F., Ledoux, J. B., & Dromain, C. (2020, Dec). The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor. Eur Radiol, 30(12), 6593-6602. https:\/\/doi.org\/10.1007\/s00330-020-06930-6","journal-title":"Eur Radiol"},{"issue":"6","key":"3509_CR28","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1007\/s00261-017-1302-5","volume":"43","author":"P Balthazar","year":"2018","unstructured":"Balthazar, P., Shinagare, A. B., Tirumani, S. H., Jagannathan, J. P., Ramaiya, N. H., & Khorasani, R. (2018, Jun). Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists' confidence in hepatic lesion assessment on restaging MRIs. Abdom Radiol (NY), 43(6), 1386-1392. https:\/\/doi.org\/10.1007\/s00261-017-1302-5","journal-title":"Abdom Radiol (NY)"},{"issue":"12","key":"3509_CR29","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2967\/jnumed.116.179234","volume":"57","author":"CM Deroose","year":"2016","unstructured":"Deroose, C. M., Hindie, E., Kebebew, E., Goichot, B., Pacak, K., Taieb, D., & Imperiale, A. (2016, Dec). Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions. J Nucl Med, 57(12), 1949-1956. https:\/\/doi.org\/10.2967\/jnumed.116.179234","journal-title":"J Nucl Med"},{"issue":"5","key":"3509_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2967\/jnumed.109.069765","volume":"51","author":"T Binderup","year":"2010","unstructured":"Binderup, T., Knigge, U., Loft, A., Mortensen, J., Pfeifer, A., Federspiel, B., Hansen, C. P., Hojgaard, L., & Kjaer, A. (2010, May). Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET. J Nucl Med, 51(5), 704-712. https:\/\/doi.org\/10.2967\/jnumed.109.069765","journal-title":"J Nucl Med"},{"issue":"11","key":"3509_CR31","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","volume":"58","author":"L Bodei","year":"2017","unstructured":"Bodei, L., Ambrosini, V., Herrmann, K., & Modlin, I. (2017, Nov). Current Concepts in (68)Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies. J Nucl Med, 58(11), 1718-1726. https:\/\/doi.org\/10.2967\/jnumed.116.186361","journal-title":"J Nucl Med"},{"issue":"7","key":"3509_CR32","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s00261-021-02990-4","volume":"46","author":"T Jackson","year":"2021","unstructured":"Jackson, T., Darwish, M., Cho, E., Nagatomo, K., Osman, H., & Jeyarajah, D. R. (2021, Jul). 68Ga-DOTATATE PET\/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis? Abdom Radiol (NY), 46(7), 3179-3183. https:\/\/doi.org\/10.1007\/s00261-021-02990-4","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"3509_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.soc.2019.11.009","volume":"29","author":"AM Laird","year":"2020","unstructured":"Laird, A. M., & Libutti, S. K. (2020, Apr). Management of Other Gastric and Duodenal Neuroendocrine Tumors. Surg Oncol Clin N Am, 29(2), 253-266. https:\/\/doi.org\/10.1016\/j.soc.2019.11.009","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"3509_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1530\/EJE-12-0836","volume":"168","author":"D Thomas","year":"2013","unstructured":"Thomas, D., Tsolakis, A. V., Grozinsky-Glasberg, S., Fraenkel, M., Alexandraki, K., Sougioultzis, S., Gross, D. J., & Kaltsas, G. (2013, Feb). Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study. Eur J Endocrinol, 168(2), 185-193. https:\/\/doi.org\/10.1530\/EJE-12-0836","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"3509_CR35","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/j.ijsu.2014.05.017","volume":"12","author":"A Cavallaro","year":"2014","unstructured":"Cavallaro, A., Zanghi, A., Cavallaro, M., Lo Menzo, E., Di Carlo, I., Di Vita, M., Cardi, F., Piccolo, G., Di Mattia, P., & Cappellani, A. (2014). The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report. Int J Surg, 12 Suppl 1, S225-231. https:\/\/doi.org\/10.1016\/j.ijsu.2014.05.017","journal-title":"Int J Surg"},{"issue":"10","key":"3509_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/RLU.0000000000003153","volume":"45","author":"MS Auerbach","year":"2020","unstructured":"Auerbach, M. S., Pisegna, J. R., Kim, S., & Yu, R. (2020, Oct). Three Cases of Diffuse, Intense Stomach Uptake on DOTATATE PET. Clin Nucl Med, 45(10), 813-816. https:\/\/doi.org\/10.1097\/RLU.0000000000003153","journal-title":"Clin Nucl Med"},{"issue":"2","key":"3509_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1148\/radiol.2020201745","volume":"298","author":"BJ Burkett","year":"2021","unstructured":"Burkett, B. J., Dundar, A., Young, J. R., Packard, A. T., Johnson, G. B., Halfdanarson, T. R., Eiring, R. A., Gansen, D. N., Patton, C. M., & Kendi, A. T. (2021, Feb). How We Do It: A Multidisciplinary Approach to (177)Lu DOTATATE Peptide Receptor Radionuclide Therapy. Radiology, 298(2), 261-274. https:\/\/doi.org\/10.1148\/radiol.2020201745","journal-title":"Radiology"},{"issue":"8","key":"3509_CR38","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2967\/jnumed.114.137166","volume":"55","author":"S Ezziddin","year":"2014","unstructured":"Ezziddin, S., Adler, L., Sabet, A., Poppel, T. D., Grabellus, F., Yuce, A., Fischer, H. P., Simon, B., Holler, T., Biersack, H. J., & Nagarajah, J. (2014, Aug). Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system. J Nucl Med, 55(8), 1260-1266. https:\/\/doi.org\/10.2967\/jnumed.114.137166","journal-title":"J Nucl Med"},{"issue":"3","key":"3509_CR39","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1158\/1078-0432.CCR-09-1759","volume":"16","author":"T Binderup","year":"2010","unstructured":"Binderup, T., Knigge, U., Loft, A., Federspiel, B., & Kjaer, A. (2010, Feb 1). 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res, 16(3), 978-985. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1759","journal-title":"Clin Cancer Res"},{"key":"3509_CR40","doi-asserted-by":"publisher","first-page":"2340389","DOI":"10.1155\/2018\/2340389","volume":"2018","author":"P Zhang","year":"2018","unstructured":"Zhang, P., Yu, J., Li, J., Shen, L., Li, N., Zhu, H., Zhai, S., Zhang, Y., Yang, Z., & Lu, M. (2018). Clinical and Prognostic Value of PET\/CT Imaging with Combination of (68)Ga-DOTATATE and (18)F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms. Contrast Media Mol Imaging, 2018, 2340389. https:\/\/doi.org\/10.1155\/2018\/2340389","journal-title":"Contrast Media Mol Imaging"},{"issue":"5","key":"3509_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1530\/EC-16-0043","volume":"5","author":"K Oberg","year":"2016","unstructured":"Oberg, K., Krenning, E., Sundin, A., Bodei, L., Kidd, M., Tesselaar, M., Ambrosini, V., Baum, R. P., Kulke, M., Pavel, M., Cwikla, J., Drozdov, I., Falconi, M., Fazio, N., Frilling, A., Jensen, R., Koopmans, K., Korse, T., Kwekkeboom, D., Maecke, H., Paganelli, G., Salazar, R., Severi, S., Strosberg, J., Prasad, V., Scarpa, A., Grossman, A., Walenkamp, A., Cives, M., Virgolini, I., Kjaer, A., & Modlin, I. M. (2016, Sep). A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. Endocr Connect, 5(5), 174-187. https:\/\/doi.org\/10.1530\/EC-16-0043","journal-title":"Endocr Connect"},{"key":"3509_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz, L. H., Litiere, S., de Vries, E., Ford, R., Gwyther, S., Mandrekar, S., Shankar, L., Bogaerts, J., Chen, A., Dancey, J., Hayes, W., Hodi, F. S., Hoekstra, O. S., Huang, E. P., Lin, N., Liu, Y., Therasse, P., Wolchok, J. D., & Seymour, L. (2016, Jul). RECIST 1.1-Update and clarification: From the RECIST committee. Eur J Cancer, 62, 132-137. https:\/\/doi.org\/10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"issue":"12","key":"3509_CR43","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s12094-018-1881-9","volume":"20","author":"X Merino-Casabiel","year":"2018","unstructured":"Merino-Casabiel, X., Aller, J., Arbizu, J., Garcia-Figueiras, R., Gonzalez, C., Grande, E., Jimenez-Fonseca, P., Sevilla, M. I., & Capdevila, J. (2018, Dec). Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors. Clin Transl Oncol, 20(12), 1522-1528. https:\/\/doi.org\/10.1007\/s12094-018-1881-9","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"3509_CR44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/01.pas.0000163363.86099.9f","volume":"29","author":"SC Abraham","year":"2005","unstructured":"Abraham, S. C., Carney, J. A., Ooi, A., Choti, M. A., & Argani, P. (2005, Jul). Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am J Surg Pathol, 29(7), 969-975. https:\/\/doi.org\/10.1097\/01.pas.0000163363.86099.9f","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"3509_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.32074\/1591-951X-229","volume":"113","author":"L Mastracci","year":"2021","unstructured":"Mastracci, L., Rindi, G., Grillo, F., Solcia, E., Campora, M., Fassan, M., Parente, P., Vanoli, A., & La Rosa, S. (2021, Feb). Neuroendocrine neoplasms of the esophagus and stomach. Pathologica, 113(1), 5-11. https:\/\/doi.org\/10.32074\/1591-951X-229","journal-title":"Pathologica"},{"issue":"6","key":"3509_CR46","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/his.14220","volume":"77","author":"VQ Trinh","year":"2020","unstructured":"Trinh, V. Q., Shi, C., & Ma, C. (2020, Dec). Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis. Histopathology, 77(6), 865-876. https:\/\/doi.org\/10.1111\/his.14220","journal-title":"Histopathology"},{"issue":"5","key":"3509_CR47","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.amjsurg.2018.12.057","volume":"217","author":"A Crown","year":"2019","unstructured":"Crown, A., Kennecke, H., Kozarek, R., Lopez-Aguiar, A. G., Dillhoff, M., Beal, E. W., Poultsides, G. A., Makris, E., Idrees, K., Smith, P. M., Nathan, H., Beems, M., Abbott, D., Fisher, A. V., Fields, R. C., Davidson, J., Maithel, S. K., & Rocha, F. G. (2019, May). Gastric carcinoids: Does type of surgery or tumor affect survival? Am J Surg, 217(5), 937-942. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.12.057","journal-title":"Am J Surg"},{"issue":"12","key":"3509_CR48","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/apt.15765","volume":"51","author":"K Exarchou","year":"2020","unstructured":"Exarchou, K., Howes, N., & Pritchard, D. M. (2020, Jun). Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours. Aliment Pharmacol Ther, 51(12), 1247-1267. https:\/\/doi.org\/10.1111\/apt.15765","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3509_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1148\/rg.271065169","volume":"27","author":"AD Levy","year":"2007","unstructured":"Levy, A. D., & Sobin, L. H. (2007, Jan-Feb). From the archives of the AFIP: Gastrointestinal carcinoids: imaging features with clinicopathologic comparison. Radiographics, 27(1), 237-257. https:\/\/doi.org\/10.1148\/rg.271065169","journal-title":"Radiographics"},{"issue":"4","key":"3509_CR50","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1053\/j.gastro.2021.06.078","volume":"161","author":"SC Shah","year":"2021","unstructured":"Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021, Oct). AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology, 161(4), 1325-1332 e1327. https:\/\/doi.org\/10.1053\/j.gastro.2021.06.078","journal-title":"Gastroenterology"},{"issue":"10","key":"3509_CR51","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1245\/s10434-011-1652-0","volume":"18","author":"MS Saund","year":"2011","unstructured":"Saund, M. S., Al Natour, R. H., Sharma, A. M., Huang, Q., Boosalis, V. A., & Gold, J. S. (2011, Oct). Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids. Ann Surg Oncol, 18(10), 2826-2832. https:\/\/doi.org\/10.1245\/s10434-011-1652-0","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"3509_CR52","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00261-016-0976-4","volume":"42","author":"YM ElGuindy","year":"2017","unstructured":"ElGuindy, Y. M., Javadi, S., Menias, C. O., Jensen, C. T., Elsamaloty, H., & Elsayes, K. M. (2017, Apr). Imaging of secretory tumors of the gastrointestinal tract. Abdom Radiol (NY), 42(4), 1113-1131. https:\/\/doi.org\/10.1007\/s00261-016-0976-4","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"3509_CR53","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.rcl.2011.02.011","volume":"49","author":"MT Heller","year":"2011","unstructured":"Heller, M. T., & Shah, A. B. (2011, May). Imaging of neuroendocrine tumors. Radiol Clin North Am, 49(3), 529-548, vii. https:\/\/doi.org\/10.1016\/j.rcl.2011.02.011","journal-title":"Radiol Clin North Am"},{"issue":"4","key":"3509_CR54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2214\/ajr.176.4.1760947","volume":"176","author":"AJ Binstock","year":"2001","unstructured":"Binstock, A. J., Johnson, C. D., Stephens, D. H., Lloyd, R. V., & Fletcher, J. G. (2001, Apr). Carcinoid tumors of the stomach: a clinical and radiographic study. AJR Am J Roentgenol, 176(4), 947-951. https:\/\/doi.org\/10.2214\/ajr.176.4.1760947","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"3509_CR55","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2214\/AJR.12.9758","volume":"201","author":"D Ganeshan","year":"2013","unstructured":"Ganeshan, D., Bhosale, P., Yang, T., & Kundra, V. (2013, Oct). Imaging features of carcinoid tumors of the gastrointestinal tract. AJR Am J Roentgenol, 201(4), 773-786. https:\/\/doi.org\/10.2214\/AJR.12.9758","journal-title":"AJR Am J Roentgenol"},{"key":"3509_CR56","volume-title":"Textbook of Gastrointestinal Radiology","author":"RLM Gore","year":"2021","unstructured":"Gore, R. L. M. (2021). Textbook of Gastrointestinal Radiology (5th ed.). Elsevier.","edition":"5"},{"issue":"3","key":"3509_CR57","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1148\/rg.2020190065","volume":"40","author":"AC Anderson","year":"2020","unstructured":"Anderson, A. C., Millet, J. D., Manganaro, M. S., & Wasnik, A. P. (2020, May-Jun). Multimodality Imaging of Gastric Pathologic Conditions: A Primer for Radiologists. Radiographics, 40(3), 707-708. https:\/\/doi.org\/10.1148\/rg.2020190065","journal-title":"Radiographics"},{"key":"3509_CR58","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jbi.2015.05.003","volume":"55","author":"DA Hanauer","year":"2015","unstructured":"Hanauer, D. A., Mei, Q., Law, J., Khanna, R., & Zheng, K. (2015, Jun). Supporting information retrieval from electronic health records: A report of University of Michigan's nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). J Biomed Inform, 55, 290-300. https:\/\/doi.org\/10.1016\/j.jbi.2015.05.003","journal-title":"J Biomed Inform"},{"key":"3509_CR59","doi-asserted-by":"publisher","first-page":"6679397","DOI":"10.1155\/2021\/6679397","volume":"2021","author":"F Panzuto","year":"2021","unstructured":"Panzuto, F., Magi, L., Esposito, G., Rinzivillo, M., & Annibale, B. (2021). Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review. Gastroenterol Res Pract, 2021, 6679397. https:\/\/doi.org\/10.1155\/2021\/6679397","journal-title":"Gastroenterol Res Pract"},{"issue":"10","key":"3509_CR60","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s11605-021-04997-0","volume":"25","author":"JH Noh","year":"2021","unstructured":"Noh, J. H., Kim, D. H., Yoon, H., Hsing, L. C., Na, H. K., Ahn, J. Y., Lee, J. H., Jung, K. W., Choi, K. D., Song, H. J., Lee, G. H., & Jung, H. Y. (2021, Oct). Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine Tumor. J Gastrointest Surg, 25(10), 2495-2502. https:\/\/doi.org\/10.1007\/s11605-021-04997-0","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"3509_CR61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/2050640619890465","volume":"8","author":"RE Rossi","year":"2020","unstructured":"Rossi, R. E., Invernizzi, P., Mazzaferro, V., & Massironi, S. (2020, Mar). Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis. United European Gastroenterol J, 8(2), 140-147. https:\/\/doi.org\/10.1177\/2050640619890465","journal-title":"United European Gastroenterol J"},{"issue":"4","key":"3509_CR62","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2214\/AJR.19.22542","volume":"215","author":"A Davila","year":"2020","unstructured":"Davila, A., Menias, C. O., Alhalabi, K., Lall, C., Pickhardt, P. J., Lubner, M., & Elsayes, K. M. (2020, Oct). Multiple Endocrine Neoplasia: Spectrum of Abdominal Manifestations. AJR Am J Roentgenol, 215(4), 885-895. https:\/\/doi.org\/10.2214\/AJR.19.22542","journal-title":"AJR Am J Roentgenol"},{"issue":"20","key":"3509_CR63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.21037\/atm.2019.09.114","volume":"7","author":"S Yan","year":"2019","unstructured":"Yan, S., Liu, T., Li, Y., Zhu, Y., Jiang, J., Jiang, L., & Zhao, H. (2019, Oct). Value of computed tomography evaluation in pathologic classification and prognosis prediction of gastric neuroendocrine tumors. Ann Transl Med, 7(20), 545. https:\/\/doi.org\/10.21037\/atm.2019.09.114","journal-title":"Ann Transl Med"},{"issue":"7","key":"3509_CR64","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s00330-015-3600-z","volume":"25","author":"SH Kim","year":"2015","unstructured":"Kim, S. H., Kim, S. H., Kim, M. A., Shin, C. I., Han, J. K., & Choi, B. I. (2015, Jul). CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas. Eur Radiol, 25(7), 1946-1957. https:\/\/doi.org\/10.1007\/s00330-015-3600-z","journal-title":"Eur Radiol"},{"issue":"3","key":"3509_CR65","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/ERC-19-0400","volume":"27","author":"H Sorbye","year":"2020","unstructured":"Sorbye, H., Kong, G., & Grozinsky-Glasberg, S. (2020, Mar). PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Endocr Relat Cancer, 27(3), R67-R77. https:\/\/doi.org\/10.1530\/ERC-19-0400","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"3509_CR66","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12020-021-02775-1","volume":"74","author":"K Exarchou","year":"2021","unstructured":"Exarchou, K., Kamieniarz, L., Tsoli, M., Victor, A., Oleinikov, K., Khan, M. S., Srirajaskanthan, R., Mandair, D., Grozinsky-Glasberg, S., Kaltsas, G., Howes, N., Pritchard, D. M., & Toumpanakis, C. (2021, Nov). Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms? Endocrine, 74(2), 421-429. https:\/\/doi.org\/10.1007\/s12020-021-02775-1","journal-title":"Endocrine"},{"issue":"2","key":"3509_CR67","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.soc.2019.11.004","volume":"29","author":"C Chandrasekharan","year":"2020","unstructured":"Chandrasekharan, C. (2020, Apr). Medical Management of Gastroenteropancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am, 29(2), 293-316. https:\/\/doi.org\/10.1016\/j.soc.2019.11.004","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"3509_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3760\/cma.j.issn.1671-0274.2020.01.007","volume":"23","author":"WQ Liang","year":"2020","unstructured":"Liang, W. Q., Zhang, W., Qiao, S., Wang, B. H., Wang, C., Zhuang, Z. W., Xi, H. Q., Cai, A. Z., Wei, B., & Chen, L. (2020, Jan 25). [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms]. Zhonghua Wei Chang Wai Ke Za Zhi, 23(1), 38-43. https:\/\/doi.org\/10.3760\/cma.j.issn.1671-0274.2020.01.007","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"7","key":"3509_CR69","doi-asserted-by":"publisher","first-page":"e2114180","DOI":"10.1001\/jamanetworkopen.2021.14180","volume":"4","author":"J Lin","year":"2021","unstructured":"Lin, J., Zhao, Y., Zhou, Y., Tian, Y., He, Q., Lin, J., Hao, H., Zou, B., Jiang, L., Zhao, G., Lin, W., Xu, Y., Li, Z., Xue, F., Li, S., Fu, W., Li, Y., Xu, Z., Li, Y., Chen, J., Zhou, X., Zhu, Z., Cai, L., Li, E., Li, H., Zheng, C., Li, P., Huang, C., & Xie, J. (2021, Jul 1). Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma. JAMA Netw Open, 4(7), e2114180. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.14180","journal-title":"JAMA Netw Open"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-022-03509-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-022-03509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T03:06:27Z","timestamp":1667358387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-022-03509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":69,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1007\/s00261-022-03509-1","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,12]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Unrelated to this manuscript, Dr. Wasnik receives book royalties from Elsevier Inc, research support from Sequana Medical, NV, payable to the University of Michigan, and has intellectual property licensed by the University of Michigan to Applied Morphomics, Inc. The other authors have no relevant disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}